Benitec Biopharma Inc. Common Stock (BNTC) is a publicly traded Healthcare sector company. As of September 14, 2026, BNTC trades at $12.09 with a market cap of $418.78M and a P/E ratio of -11.58. BNTC moved -0.41% today. Year to date, BNTC is -10.32%; over the trailing twelve months it is -12.78%. Its 52-week range spans $9.70 to $17.15. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces BNTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BNTC, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $12.09 |
| Market Cap | $418.78M |
| P/E Ratio | -11.58 |
| EPS | $-1.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.15 |
| 52-Week Low | $9.70 |
| Volume | 84.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-37.92M |
| Gross Margin | 0.00% |
1 analysts cover BNTC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.